CARDLYTICS sees an upgrade to Slightly Negative thanks to a better star rating, but the title remains unattractive
The independent financial analyst theScreener just awarded an improved star rating to CARDLYTICS (US), active in the Media Agencies industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 2 out of 4 possible stars. Given its market behaviour as risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Slightly Negative; the title, however, remains unattractive. As of the analysis date February 1, 2022, the closing price was USD 70.06 and its target price was estimated at USD 44.36.Cardlytics is engaged in operating an advertising platform. The company has two reportable segments: Cardlytics Direct and Other Platform Solutions. Through Cardlytics Direct, marketers can deliver advertising content to financial institutions (FIs) customers in the form of an opportunity to earn rewards, which are funded with a portion of the fees the company collects from marketers. The company sells Cardlytics Direct in the United States and the United Kingdom. The company's Other Platform Solutions enabled marketers and marketing service providers to utilize the power of purchase intelligence outside the bank channel.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.